OHT - OCULAR HYPERTENSION
Clinical trials for OHT - OCULAR HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new OHT - OCULAR HYPERTENSION trials appear
Sign up with your email to follow new studies for OHT - OCULAR HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New eye drop combo aims to lower pressure in glaucoma patients
Disease control CompletedThis study tests a new preservative-free eye drop combination (QLS-111-FDC) to lower eye pressure in people with open-angle glaucoma or ocular hypertension. About 60 adults with mild to moderate disease will receive the treatment. The goal is to see if it safely reduces eye press…
Matched conditions: OHT - OCULAR HYPERTENSION
Phase: PHASE2, PHASE3 • Sponsor: Qlaris Bio, Inc. • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Scientists probe eye fluid secrets to personalize glaucoma treatment
Knowledge-focused CompletedThis study looked at how the eye produces and drains fluid to understand why glaucoma medications lower eye pressure more in some people than others. Researchers measured eye fluid production, drainage, and pressure in 59 adults with glaucoma or high eye pressure before and after…
Matched conditions: OHT - OCULAR HYPERTENSION
Phase: PHASE4 • Sponsor: Ohio State University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC